Literature DB >> 7181936

Sex differences in the metabolism of hexachlorobenzene by rats and the development of porphyria in females.

M Rizzardini, A G Smith.   

Abstract

Male and female F 344 rats were dosed every other day for 103 days with 50 mumole of hexachlorobenzene (HCB)/kg. Females developed a hepatic porphyria, the urine and liver levels of porphyrins being 40- and 310-fold higher respectively than those of males. Urine was periodically hydrolysed and analysed for the three metabolites pentachlorophenol, 2,3,5,6-tetrachlorobenzene-1,4-diol and pentachlorothiophenol (derived from the mercapturate). The combined urinary excretion of these was greater in females than males, especially during the first 10 weeks. Pentachlorothiophenol was particularly high in female urine. After 103 days this metabolite was slightly less in female faeces than in male's but free hepatic pentachlorothiophenol was 3.6-fold greater. Although total 24 hr excretions of metabolites were higher by females than males and after 7 daily doses of HCB, a difference in this respect was not conclusively proven. However, total pentachlorothiophenol excretion was always significantly greater by females. The male/female ratios for pentachlorophenol and pentachlorothiophenol in bile were identical to those for faeces. Excretion of metabolites by both adult males and females was stimulated by pretreatment with diethylstilboestrol (DES). No sex differences in metabolism were observed with immature rats.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7181936     DOI: 10.1016/0006-2952(82)90573-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice.

Authors:  A G Smith; J E Francis
Journal:  Biochem J       Date:  1983-09-15       Impact factor: 3.857

2.  Mechanistic studies of the inhibition of hepatic uroporphyrinogen decarboxylase in C57BL/10 mice by iron-hexachlorobenzene synergism.

Authors:  A G Smith; J E Francis; S J Kay; J B Greig; F P Stewart
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

3.  Biochemical, morphological and flow-cytometric evaluation of the effects of hexachlorobenzene on rat liver.

Authors:  M Rizzardini; L Cantoni; P Villa; P Ubezio
Journal:  Cell Biol Toxicol       Date:  1990-04       Impact factor: 6.691

4.  Metabolism of hexachlorobenzene in humans: association between serum levels and urinary metabolites in a highly exposed population.

Authors:  J To-Figueras; M Sala; R Otero; C Barrot; M Santiago-Silva; M Rodamilans; C Herrero; J Grimalt; J Sunyer
Journal:  Environ Health Perspect       Date:  1997-01       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.